Compugen Ltd. (CGEN)

NASDAQ: CGEN · Real-Time Price · USD

2.040

-0.020 (-0.97%)

At close: Mar 27, 2026, 4:00 PM EDT

2.060

+0.020 (0.98%)

After-hours: Mar 27, 2026, 6:38 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research, Development & Commercialization of Therapeutic & Product Candidates	72.76M	27.86M	33.46M	7.50M	6.00M
Research, Development & Commercialization of Therapeutic & Product Candidates Growth	161.14%	-16.72%	346.12%	25.00%	200.00%
Total	72.76M	27.86M	33.46M	7.50M	6.00M
Total Growth	161.14%	-16.72%	346.12%	25.00%	200.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United Kingdom	65.00M	5.00M	10.00M	-	-
United Kingdom Growth	1200.00%	-50.00%	-	-	-
United States	7.76M	22.86M	23.46M	-	-
United States Growth	-66.04%	-2.54%	-	-	-
Europe	-	-	-	7.50M	6.00M
Europe Growth	-	-	-	25.00%	200.00%
Total	72.76M	27.86M	33.46M	7.50M	6.00M
Total Growth	161.14%	-16.72%	346.12%	25.00%	200.00%

Source: S&P Global Market Intelligence.